Analgesic Adverse Reaction
13
0
0
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
7.7%
1 terminated out of 13 trials
91.7%
+5.2% vs benchmark
38%
5 trials in Phase 3/4
0%
0 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (13)
Neurobehavioral Development in Toddlers and Preschoolers in Relation to Prenatal Exposure of Mild Analgesics (NeuroToP - a COPANA Follow up)
Safety of Ibuprofen After Major Orthopaedic Surgeries
The Copenhagen Analgesic Study
Parecoxib in Total Knee Arthroplasty
Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy
The Effects of Mydriatic Eye Drops in Retinopathy of Prematurity Examinations
Neodolpasse® Infusion Solution Versus Diclofenac 75 mg Infusion in the Treatment of Postoperative Pain After Elective Knee Surgery
Comparation Analgesia Efficiency With Propofol Combine Sevoflurane vs Propofol
The Correlation Between Sevoflurane and qNOX
The Use of Midazolam and Remifentanil During Dialysis Access Procedures
Psoas Compartment Block (PCB) Versus L.A Infiltration and Remifentanil Infusion During EVAR
Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty
Oxycodone in Serum After Postoperative Oral Oxycodone in Caesarean Sections Under Spinal Anesthesia